1. Home
  2. JAGX vs NDRA Comparison

JAGX vs NDRA Comparison

Compare JAGX & NDRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Jaguar Health Inc.

JAGX

Jaguar Health Inc.

N/A

Current Price

$0.87

Market Cap

4.9M

Sector

Health Care

ML Signal

N/A

Logo ENDRA Life Sciences Inc.

NDRA

ENDRA Life Sciences Inc.

N/A

Current Price

$4.47

Market Cap

5.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
JAGX
NDRA
Founded
2013
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.9M
5.5M
IPO Year
2014
2016

Fundamental Metrics

Financial Performance
Metric
JAGX
NDRA
Price
$0.87
$4.47
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$60.00
$30.00
AVG Volume (30 Days)
104.5K
14.4K
Earning Date
04-07-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
82.42
84.32
EPS
N/A
N/A
Revenue
$11,511,000.00
N/A
Revenue This Year
$61.58
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.22
$2.96
52 Week High
$8.00
$9.83

Technical Indicators

Market Signals
Indicator
JAGX
NDRA
Relative Strength Index (RSI) 24.13 45.08
Support Level $0.60 $4.15
Resistance Level $0.99 $4.90
Average True Range (ATR) 0.09 0.31
MACD 0.03 -0.00
Stochastic Oscillator 9.01 62.22

Price Performance

Historical Comparison
JAGX
NDRA

About JAGX Jaguar Health Inc.

Jaguar Health Inc is a commercial-stage pharmaceutical company developing novel proprietary prescription medicines sustainably derived from plants from rainforest areas for gastrointestinal disease states in humans and animals. The Company focuses on conditions associated with overactive bowel, including chronic debilitating diarrhea, urgency, and bowel incontinence. It operates through two segments: animal health, which develops and commercializes products for animals, and human health, with the human health segment generating the maximum revenue and focusing on products such as Mytesi, focusing on human products, specifically Mytesi, approved for symptomatic relief of non-infectious diarrhea in adults with HIV/AIDS on antiretroviral therapy.

About NDRA ENDRA Life Sciences Inc.

ENDRA Life Sciences Inc is engaged in the development of Thermo Acoustic Enhanced UltraSound (TAEUS) to visualize tissue like MRI at the cost and at the point of patient care. TAEUS is designed to work in concert with around 400,000 cart-based ultrasound systems in use globally today. TAEUS is initially focused on the measurement of fat in the liver as a means to assess and monitor Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH), chronic liver conditions that affect over one billion people globally, and for which there are no practical diagnostic tools. Beyond the liver, the firm is exploring several other clinical applications of TAEUS, including visualization of tissue temperature during energy-based surgical procedures.

Share on Social Networks: